EnGeneIC

Why investors have put $100m behind Australian biotech’s ‘Trojan horse’ for cancer

From deathbed promise to cancer breakthrough: Why big pharma is watching this Aussie biotech in Phase-2 trials. Dr Jennifer MacDiarmid and Dr Himanshu Brahmbhatt are both working on animal vaccines for the CSIRO in the late 1990s when one of their best lab technicians starts coughing blood at the bench. Rushed to hospital, the 40-year-old […]

From beer to biotech: Young Henrys’ mission to save the planet

The craft brewer leverages tech that allows its inner-city brewery to produce as much oxygen as 2 hectares of bushland – while reducing emissions from your burger. Young Henrys made its name brewing tinnies for tattooed inner-city drinkers. Now, the cult beer company is spinning out a biotech startup to save the planet with cleaner […]

How an Aussie DJ and his surf crew built a $12 million drinks brand – without spending a cent on ads

Launched by Grammy-nominated artist DJ Fisher and a tight-knit crew on the Gold Coast, Hard FIZZ has grown into a $12 million drinks brand in just four years, without a cent spent on traditional advertising. Instead, it’s relied on guerrilla marketing to fuel national growth. When Paul Fisher, known globally by his stage name FIsher, […]

Stablecoins are coming for the US debt market

As the Trump administration fast-tracks stablecoin regulation, analysts are beginning to predict surging demand for U.S. Treasurys. This story was featured in Issue 17 of Forbes Australia. Tap here to secure your copy. Brian Moynihan, the chief executive officer of $2.6 trillion (assets) Bank of America, doesn’t usually make headlines for his crypto opinions. But in February, he […]

Trading the Chaos: How investors are navigating 2025’s market minefield

Whether seeking shelter or chasing opportunity, data journalist Juliette O’Brien explores how investors are navigating the so-called ‘untradeable’ market.  This story was featured in Issue 17 of Forbes Australia. Tap here to secure your copy. Markets need movement. Without price shifts, there is no profit. Volatility is part of the game, and investors have learned to navigate it.  […]

The Aussie startup using mirrors to tackle a $30 billion energy problem

The solar tech company, Impacts Renewable Energy, is heating up Australia’s industry.  This story was featured in Issue 17 of Forbes Australia. Tap here to secure your copy. We all know the sting of hot water from a garden hose on a summer’s day – but Trevor Powell, CEO and founder of Impacts Renewable Energy, saw more than […]

Ferrari’s 12Cilindri shows why the V12 is far from dead

Carving 229 kilometres of Tuscan mountain roads, Ferrari’s 830-horsepower 12Cilindri Spider – quite possibly the marque’s final unassisted V12 – proves the twelve-cylinder still thrills even as Ferrari’s electric era looms. This story was featured in Issue 17 of Forbes Australia. Tap here to secure your copy. It wasn’t supposed to end like this – crawling through the […]

Where I’m putting the money: Jared Pohl

Jared Pohl is Director and co-founder of ECP Asset Management – an active equity specialist launched in 2012 and now with more than $3 billion under management. He spoke to Stewart Hawkins about the challenges of working in a volatile market, the opportunities and dangers of AI, the nuances (and potential costs) of trading ethically […]

Venstra Medical

Why this Aussie-made pump could outperform a $17 billion rival

Venstra Medical’s heart pump promising better results for smaller patients – such as women – was among a raft of heart and diabetes companies to receive $12 million in grants last week. Australian start-up Venstra Medical has developed what it claims to be the world’s smallest and most powerful percutaneous ventricular assist device [pVAD] for […]